newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO and REDWOOD CITY, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a biopharmaceutical company pioneering the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, to